Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | REGN5459 |
Synonyms | |
Therapy Description |
REGN5459 is a bispecific human antibody targeting both human B-cell maturation antigen (BCMA, TNFRSF17) and CD3, which may increase antitumor immune response (Cancer Res (2023) 83 (8_Supplement): CT013). |